In breakthrough, nerve connections are regenerated after spinal cord injury

August 8, 2010

Researchers for the first time have induced robust regeneration of nerve connections that control voluntary movement after spinal cord injury, showing the potential for new therapeutic approaches to paralysis and other motor function impairments.

In a study on rodents, the UC Irvine, UC San Diego and Harvard University team achieved this breakthrough by turning back the developmental clock in a molecular pathway critical for the growth of corticospinal tract nerve connections.

They did this by deleting an enzyme called PTEN (a phosphatase and tensin homolog), which controls a molecular pathway called mTOR that is a key regulator of cell growth. PTEN activity is low early during development, allowing . PTEN then turns on when growth is completed, inhibiting mTOR and precluding any ability to regenerate.

Trying to find a way to restore early-developmental-stage cell growth in injured tissue, Zhigang He, a senior neurology researcher at Children's Hospital Boston and Harvard Medical School, first showed in a 2008 study that blocking PTEN in mice enabled the regeneration of connections from the eye to the brain after optic nerve damage.

He then partnered with Oswald Steward of UCI and Binhai Zheng of UCSD to see if the same approach could promote nerve regeneration in injured sites. Results of their study appear online in .

"Until now, such robust nerve regeneration has been impossible in the spinal cord," said Steward, anatomy & neurobiology professor and director of the Reeve-Irvine Research Center at UCI. "Paralysis and loss of function from spinal cord injury has been considered untreatable, but our discovery points the way toward a potential therapy to induce regeneration of following spinal cord injury in people."

According to Christopher & Dana Reeve Foundation data, about 2 percent of Americans have some form of paralysis resulting from spinal cord injury, which is due primarily to the interruption of connections between the brain and spinal cord.

An injury the size of a grape can lead to complete loss of function below the level of injury. For example, an injury to the neck can cause paralysis of arms and legs, loss of ability to feel below the shoulders, inability to control the bladder and bowel, loss of sexual function, and secondary health risks including susceptibility to urinary tract infections, pressure sores and blood clots due to an inability to move the legs.

"These devastating consequences occur even though the spinal cord below the level of injury is intact," Steward noted. "All these lost functions could be restored if we could find a way to regenerate the connections that were damaged."

He and his colleagues are now studying whether the PTEN-deletion treatment leads to actual restoration of motor function in mice with spinal cord injury. Further research will explore the optimal timeframe and drug-delivery system for the therapy.

Provided by University of California - Irvine

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

DaveGee
Aug 08, 2010

Rank: 5 / 5 (6)
It must be so very frustrating to people suffering with similar conditions... On one hand YES this is such a promising treatment yet at the same time this will continue to be relegated to the lab for a few more years and perhaps a human test being made public every once and again. Hopefully the procedure gets replicated in other countries where the path to being approved for human use is much quicker than here in the US.

Now I'm not going to debate on the speed at which medical approvals happen here in the US is good or bad but being someone who has a stage IVb cancer, I hope you can excuse me for leaning toward the faster is better mindset. I've been living on borrowed time for the past few years so that clearly has an influence on me.
zz6549
Aug 08, 2010

Rank: 4.4 / 5 (5)
I completely agree with you. The medical approval procedure in America is far behind the pace of innovation. It is unfortunate this is the case in the country that does the majority of the world's medical research.

I think that Asian countries will be the best bet for access to "unproven" medical procedures, as it's unlikely the FDA will make it any easier in the near future. India and China may not be known for their healthcare, but I think that will change in the coming decade.
Foundation
Aug 08, 2010

Rank: 5 / 5 (5)
But those Asian countries may also become known for the next Thalidomide. Looser regulations can cut both ways unfortunately.

I'm all for experimental and cutting edge medicine, but only if the patient fully understands that experimental medicine is potentially lethal. If you're going to die of cancer, or stuck in a wheelchair for the rest of your life, sure. If you're experiencing morning sickness (as was the case of Thalidomide) you should take something else and/or slug it out until the FDA is through with it.
DaveGee
Aug 08, 2010

Rank: 5 / 5 (3)
Yep we all seem to be on the same page. In short these new medical procedures should have a faster track then they do now and without enormous amounts of red tape current fact tracking approvals have today. At this stage in my life ... I wouldn't think twice about undergoing a procedure that might only have a 20% chance of working ... Provided the researchers would learn from my participation even if the worst outcome came true.

A good example of this is the treatment of macular degeneration... My wifes dad is rapidly going blind and with little hope of recovery. Now just yesterday I learned that doctors in Germany have a treatment that they've been using for well over a year now. The treatment is quite simple and involves stem cells extracted from the patients own bone. It basically stops any further progression in both wet & dry versions of the condition. It seems to have some ability to reverse the damage but it seems to be limited. Here in the US citizens are still going blind.
fixer
Aug 09, 2010

Rank: 5 / 5 (1)
@DaveGee
I have posted this link several times, and this is available now.
http://www.physor...379.html
If your local chemist doesn't stock it try here.
http://www.myvita...cap.html

Most people read the posts but never bother to go any further, I did and am alive because of this product.
kshultz222_yahoo_com
Aug 09, 2010

Rank: 3.5 / 5 (2)
Approval time should be related to the severity of the illness and chances for making things worse. Cancer and paralysis treatments should be on really fast tracks; pimples and gray hair should be treated differently. Why is so hard to figure out???
Three and five year waits (or more) for terminally ill patients is ridiculous.
As long as it is impossible to sue someone if you have signed off on the dangers, then there should be little to no liability issues for the researchers.
gopher65
Aug 09, 2010

Rank: 4.8 / 5 (4)
The problem is that it *isn't* impossible to sue the research company even if you've signed off on the dangers. It isn't uncommon for the families of test subjects to sue the companies preforming the tests, despite the fact that the patients knew darned well that it was a highly experimental treatment with potentially lethal consequences (...which covers every experimental treatment, pretty much).

Until the "sue their pants off because I spilt hot coffee on myself" culture in the USA goes away, companies and government labs will continue to take the cautious path with drug development.
DaveGee
Aug 09, 2010

Rank: not rated yet
@DaveGee
I have posted this link several times, and this is available now.
Most people read the posts but never bother to go any further, I did and am alive because of this product.


Wow, thanks... That's something I've gotta look into... I've got stage IVb lung cancer with no tumors... You'd think that was a good thing until you leered the cancer has taken over several lymph nodes. Between the two... Trust me you'd rather have a tumor somwere far away from your lymphatic system... It's like a super highway to everywhere else and let's the cancer pop up just about anywhere. Thanks again for that link... Gotta see what cancers it does well with.
Modernmystic
Aug 12, 2010

Rank: 2.5 / 5 (2)
The FDA kept beta blockers off the US market for 10 years despite wide sucess in Europe. Beta blockers save about 10,000 lives a year.

The headline when they did approve the drug was "FDA approves new wonder drug to save an estimated 10,000 lives a year".

It wasn't "The FDA killed 100,000 before finally approving a drug that's worked for 10 years in the market".
Rank 5 /5 (35 votes)
Related Stories
Relevant PhysicsForums posts
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

FDA-approved drug rapidly clears amyloid from the brain, reverses Alzheimer's symptoms in mice

Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The researchers' findings, published in the journal Science, show t ...

Medicine & Health / Neuroscience

created 8 hours ago | popularity 5 / 5 (28) | comments 6 | with audio podcast

Anyone can learn to be more inventive, cognitive researcher says

There will always be a wild and unpredictable quality to creativity and invention, says Anthony McCaffrey, a cognitive psychology researcher at the University of Massachusetts Amherst, because an "Aha moment" is rare and ...

Medicine & Health / Psychology & Psychiatry

created 4 hours ago | popularity 4.5 / 5 (2) | comments 0 | with audio podcast

Cell biologists describes mechanism by which some people may be more susceptible to colon cancer

An international research team led by cell biologists at the University of California, Riverside has uncovered a new insight into colon cancer, the third leading cause of cancer-related deaths in the United ...

Medicine & Health / Cancer

created 5 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Researchers weigh in on ethics of H5N1 research

(Medical Xpress) -- In a commentary on the biosecurity controversy surrounding publication of bird flu research details, a bioethicist and a vaccine expert at Johns Hopkins reaffirm that "all scientists have an affirmativ ...

Medicine & Health / Other

created 7 hours ago | popularity not rated yet | comments 0 | with audio podcast

Scientists identify most lethal known species of prion protein

Scientists from the Florida campus of The Scripps Research Institute have identified a single prion protein that causes neuronal death similar to that seen in "mad cow" disease, but is at least 10 times more ...

Medicine & Health / Research

created 7 hours ago | popularity 5 / 5 (3) | comments 2 | with audio podcast


'Dark plasmons' transmit energy

Microscopic channels of gold nanoparticles have the ability to transmit electromagnetic energy that starts as light and propagates via "dark plasmons," according to researchers at Rice University.

Hydrogen from acidic water: Researchers develop potential low cost alternative to platinum for splitting water

A technique for creating a new molecule that structurally and chemically replicates the active part of the widely used industrial catalyst molybdenite has been developed by researchers with the Lawrence Berkeley ...

Ultraviolet protection molecule in plants yields its secrets

Lying around in the sun all day is hazardous not just for humans but also for plants, which have no means of escape. Ultraviolet (UV) radiation from the sun can damage proteins and DNA inside cells, leading ...

New method makes culture of complex tissue possible in any lab

Scientists at the University of California, San Diego have developed a new method for making scaffolds for culturing tissue in three-dimensional arrangements that mimic those in the body. This advance, published online in ...

Flexible paper robots

(PhysOrg.com) -- These inexpensive robots can stretch, bend and twist under control, and lift objects up to 120 times their own weight. Being soft, they can apply gentle and even pressure, and adapt to varied ...

Deadly bird parasite evolves at exceptionally fast rate

A new study of a devastating bird disease that spread from poultry to house finches in the mid-1990s reveals that the bacteria responsible for the disease evolves at an exceptionally fast rate. What's more, ...